Read More

医思健康携手凯龙瑞及亚洲联合基建成立合资公司

HONG KONG, Jun 6, 2022 - (亚太商讯 via SEAPRWire.com) - 香港最大非医院医疗服务机构*──医思健康(「公司」,连同附属公司,统称「集团」;香港联交所股份编号:2138)欣然宣布,集团与房地产投资管理公司凯龙瑞集团(「凯龙瑞」)及亚洲联合基建控股有限公司(「亚洲联合基建」;香港联交所股份编号:0711)成立合资公司(「合资公司」),联合于香港兴建优质的医疗级别专用大厦(「医疗大厦」)。大厦落成后集团将成为主要承租人。集团已有条件同意向合资公司作出不多于275百万港元的初步出资,占合资公司已扩大发行股本总额的30%。集团亦将就医疗大厦订立租约,初步租约为期5年,并可选择续租5年。医疗大厦预期将于2024年第四季度落成。医疗大厦位于金马伦道尖沙咀核心商业区,预计可出租楼面面积约103,000平方呎。基于达成的租户与业主双边赋能合作关系,集团将参与兴建这一独特的医疗级别专用大厦,以推动集团的业务增长及未来策略发展。集团亦将取得大厦冠名权,将有助于集团提升品牌知名度。于该医疗大厦中,集团将进行定制化医疗用途布局使其得以容纳专业的医疗器械,提供优越一站式的医疗及医美服务。集团计划将其他分散在香港九龙不同大厦的诊所整合至此,并预期该专用大厦可提升医疗健康服务水平以及营运效率。医思健康执行董事兼首席策略总监及首席投资总监王家琦女士表示:「医疗大厦将成为集团于香港开展优质医疗健康服务的核心场景。是次战略落地展示了集团对打造以优质服务为核心的闭环医疗生态系统之承诺,巩固了集团作为一站式综合医疗健康服务提供商的领先地位。医疗大厦落成后将成为集团策略的关键支柱,可为客户提供一站式无缝衔接的医疗健康服务体验。我们对能够达成此次开创性的医疗租户与业主双边赋能合作倍感荣幸,凭借集团于医疗健康服务领域的市场领先经验,以及合作伙伴凯龙瑞及亚洲联合基建的丰富房地产及建筑经验,集团期待将香港及其他地区的优质医疗健康服务水平提升至新的高度。 」凯龙瑞集团香港首席执行官何震东先生表示:「我们很高兴能够与知名医疗机构医思健康及亚洲联合基建开展合作,于尖沙咀中心地段兴建一幢医疗专用大厦,从而把握香港对医疗房地产日益增长的需求。」亚洲联合基建主席彭一庭先生表示:「亚洲联合基建很高兴能够与医思健康及凯龙瑞合作兴建此意义非凡的项目。亚洲联合基建一直致力于改善香港市民的生活。随着社会大众对健康及健康的意识不断提高,我们相信该兴建项目不仅能够令合资公司伙伴受益,同时亦有利于社会大众。」关于医思健康香港最大非医院医疗服务供应商*医思健康以预防及精准医疗为业务核心,透过多元服务整合发展医疗人工智慧,配套高端品牌及优质客户服务,致力为客户提供最专业、安全、有效的医疗健康服务。此举以集团高端品牌及优质客户服务为支撑,旨在为客户提供安全且有效的专业医疗健康服务。集团目前直营的诊...

CUHK Professor Elaine Chow Receives “2022 Women’s Interprofessional Network of the American Diabetes Association Abstract Award” for Outstanding Research and Care in Diabetes

HONG KONG, Jun 5, 2022 - (ACN Newswire via SEAPRWire.com) - Professor Elaine YK Chow from the Faculty of Medicine at The Chinese University of Hong Kong has received the "2022 Women's Interprofessional Network of the American Diabetes Association Abstract Award" in the category of Clinical Diabetes, Epidemiology, and Diabetes Complications in recognition of her outstanding results and significant contributions in the SENSITIZE study and the whole field of diabetes research. The WIN ADA abstract award category of Clinical Diabetes, Epidemiology, and Diabetes Complications is an important part of WIN ADA awards, voted by WIN ADA Advisory Group, consisting of expert clinicians, scientists, educators, public health practitioners, and other diabetes professionals. It honours women who have made significant contributions to the diabetes research, clinical care, public health, education, and related areas worldwide. The award was presented to Professor Elaine on June 3, 2022.Professor Elaine will present a clinical study called SENSITIZE, which explored the effects of dorzagliatin, the global first-in-class drug, glucokinase activator (GKA) at the ADA Annual Scientific Sessions. This stud...

香港中文大学周怡君教授荣获 2022 WIN ADA Award,以表彰其在糖尿病领域的优异研究成果及贡献

HONG KONG, Jun 5, 2022 - (亚太商讯 via SEAPRWire.com) - 来自香港中文大学医学院的周怡君教授荣获ADA(美国糖尿病协会)科学顾问团评选的「Women's Interprofessional Network of the ADA (WIN ADA) abstract award」(临床糖尿病、流行病学和糖尿病并发症类-2022女性专业网络摘要奖),以表彰她在SENSITIZE研究以及整个糖尿病研究领域的优异成果和贡献。「临床糖尿病、流行病学和糖尿病并发症类」摘要奖是WIN ADA奖项的重要类别,其由临床专家、科学家、教育工作者和公共卫生从业人员以及其他糖尿病专业人员组成的WIN ADA顾问团队评选,以表彰在全球范围内对糖尿病研究、临床护理、公共卫生、教育和相关领域作出杰出贡献的女性。周教授将会在2022年第82届美国糖尿病协会科学会议对一项名为SENSITIZE的临床研究成果进行口头报告,该项报告主要对全球首创新药葡萄糖激酶激活剂(GKA)多格列艾汀(dorzagliatin)的效果进行更深入的探索。该研究由国际内分泌专家、香港中文大学Juliana Chan教授作为研究者发起,探索多格列艾汀对初发2型糖尿病和葡萄糖激酶单基因遗传突变糖尿病 (GCK-MODY或MODY-2)患者的影响。 Copyright 2022 亚太商讯. All rights reserved. (via SEAPRWire)

Read More

Klaytn-based mining NFT ‘KlayStore’ Starts first minting on June 7th

New York, NY, June 3, 2022 - (ACN Newswire via SEAPRWire.com) - Klaytn network-based Metaverse Service, 'KlayStore' launches the first minting service on June 7, 2022. A total of 14,000(2,000 per character) limited edition NFT of various job characters is minted, and a staking pool is provided to NFT holders in the first round.The maximum number of KlayStore's minted NFT is 5,000 per character. KlayStore plans to mint 3,000 NFT per character in the next round.Starting from the first minting, staking can be done via STC every day for ten years. Once people mint an NFT by mining power (MP) through this service, users can occupy the world's popular places and landmarks in advance and get rewards for a long time. MP is changed by the levels of characters that users have created or selected and various mining rating systems.Minted character NFT acquires mining power (MP), which becomes the standard of staking pool. In addition, the rewarded STC is planned to be exchanged to KLAY via KLAY swap and converted into cash.Since users can participate in the minting on Klaytn this time, they need a Kaikas or Metamask wallet for using the service. Check KlayStore website (https://klaystore.io/) ...

Read More

Society Pass (SoPa) Acquires SG-based Gorilla Networks, a Next-Gen Blockchain/Web3 Virtual Network Operator, to Drive SEA’s Growing Demand for a New Metaverse Experience

SINGAPORE, Jun 3, 2022 - (ACN Newswire via SEAPRWire.com) - Society Pass Incorporated (SoPa) (Nasdaq: SOPA), Southeast Asia's leading data-driven loyalty and ecommerce ecosystem, announced today that it acquired Singapore-based Gorilla Networks Pte Ltd ("Gorilla"), a leading next-generation Web3-enabled MVNO.Established in Singapore in 2019, Gorilla uses Web3 technology to operate an MVNO for its users in Southeast Asia. With network coverage to over 160 countries, Gorilla offers a full suite of mobile communication services such as local calls, international roaming, data, and SMS texting. More importantly, Gorilla enables its customers to convert unused mobile data into digital assets or Gorilla GO Tokens through its innovative proprietary blockchain-based SwitchBack feature. Gorilla GO Tokens in turn can be redeemed for eVouchers, to offset future bills, or be redeemed for other value-added services. With the rebound of the travel market throughout Southeast Asia in 2Q/3Q 2022, Gorilla expects to dramatically increase its customer base by marketing to the region's business and leisure travellers with its user-friendly technology platform. It plans to expand its MVNO services off...

Read More

Moonstake Hosts Staking Contest with Partner FIO with 100,000 FIO Prize Pool

SINGAPORE, Jun 3, 2022 - (ACN Newswire via SEAPRWire.com) - Moonstake is excited to host a staking contest with our partner, FIO, with a prize pool of 100,000 FIO tokens. This competition will run from June 1 - June 15 and there will be 108 prizes for users who stake the most as well as lucky draw rewards.Moonstake and FIO became strategic partners in February 2022 to integrate support for FIO tokens on Moonstake Wallet, and Moonstake became an official Block Producer for the FIO Network in the same month. Since then, Moonstake and FIO have collaborated extensively to host various successful community programs to promote adoption of the FIO and Moonstake ecosystems, including staking launch, educational quiz, and now, a staking contest to boost awareness and participation.Below is the detailed information of the FIO staking contest:Reward details:- First place: 1 prize of 20,000 FIO tokens. Must stake a minimum of 200,000 FIO tokens.- Second place: 2 prizes of 10,000 FIO tokens each. Must stake a minimum of 100,000 FIO tokens.- Third place: 5 prizes of 4,000 FIO tokens each. Must stake at least 40,000 FIO tokens.- Lucky draw prizes: 100 randomly selected participants will share a t...

Read More

First In-Person Satellite Industry Forum After COVID Sees the Industry in Strong Shape and Geared for Growth

Singapore, Jun 3, 2022 - (ACN Newswire via SEAPRWire.com) - The Asia Video Industry Association was finally able to host its annual Satellite Industry Forum in-person in Singapore on 31st May 2022 after a two-year hiatus, bringing together over 120 delegates from around the world and some of the satellite industry's most foremost leaders. Opening the Forum this year was keynote speaker, Steve Collar, Chief Executive Officer, SES, to address the issue of where future growth was coming from and kicked off the session with his views on demand and supply in the market. As platforms were getting longer to get built and become operational, it showed how difficult it was to get launches done, and how much the industry overestimated supply. Collar added that SES had always been a champion of multi-orbit, and not just having both MEO and GEO satellites, but also constructing a global network for customers to move seamlessly from one to the other to maximize the benefits of both. Collar also shared his excitement on demand, and the new applications and new services that could be run, with a sweet spot being the high throughput and high connectivity services which represented a significant ma...

Read More

Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies

Ingelheim, Germany and Singapore, Jun 2, 2022 - (ACN Newswire via SEAPRWire.com) - Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR. Boehringer Ingelheim aims to use these antibodies to direct therapeutic effector mechanisms such as antibody-drug conjugates (ADCs) and T-cell engagers exclusively to tumor cells, and to that end develop a range of highly targeted cancer treatments.EDDC staff planning the automation of an antibody engineering process"Boehringer Ingelheim believes that these promising antibodies in-licensed from A*STAR will help us advance potent therapeutic candidates against key molecular cancer targets," says Clive R. Wood, Senior Corporate Vice President and Global Head of Discovery Research at Boehringer Ingelheim and continues: "We look forward to developing these assets for a broad range of cancers with the goal to deliver breakthrough opportunities for patients."Boehringer Ingelheim is pioneering a...

Read More

Novotech 赞助 ASCO 中国峰会前中美早期肿瘤试验和监管策略专家组

SYDNEY, Jun 3, 2022 - (亚太商讯 via SEAPRWire.com) - Novotech 是亚太地区领先的生物技术专家 CRO,最近将其服务扩展到美国,在 2022 年 ASCO 前中国峰会上赞助了专家小组,汇集了中国和美国肿瘤药物开发的领导者。Pre-ASCO 系列在全球有超过 20,000 人观看。Novotech 赞助的峰会会议包括:- 基于早期肿瘤学试验的 Go/No Go 决策 - 在这里观看 https://tinyurl.com/novotech-webinars - 中国和美国的发展和监管战略 - 在这里观看 https://tinyurl.com/novotech-whitepapers中国为加速临床试验提供了一个令人信服的解决方案,尤其是在肿瘤学领域,拥有庞大的患者群体和世界级的 KOL。 -- 根据全球数据白皮书: 与美国和欧盟相比,亚太地区临床试验的演变5 (https://tinyurl.com/novotech-whitepapers)- 过去 5 年,中国肿瘤学试验的增长(复合年增长率为 25%)超过了其他国家。- 这一增长与癌症发病率的显着增加、国内公司开发创新产品、专注于免疫肿瘤学以及在细胞治疗方面的领导地位有关- 中国也记录了最多的新试验,其次是美国。在中国,2017-2021 年期间,新试验的数量翻了一番。值得注意的是,中国的监管改革通过减少整体审查和流程加快了药品审批。- 此外,在过去五年中,在亚太地区、美国和欧盟5 注册了超过 70,000 项新的临床试验。亚太地区是最大的贡献者,超过 50% 的试验其次是美国(29%)和欧盟五国(17%)。- 亚太地区已成为开展临床试验的首选目的地,因为其患者人数众多、易于遵守法规、开展研究的成本低、高质量标准和顶级临床站点的存在。本月早些时候,Novotech 宣布收购美国 CRO、NCGS,作为其全球客户群的美国服务扩展计划的一部分。Novotech 在亚太地区以提供全方位服务、高质量的快速临床试验而享有盛誉,现在可以在美国为其生物技术客户提供临床服务,以支持后期的全球研究。NCGS 于 1984 年在南卡罗来纳州成立,拥有生物制药客户群。 NCGS 在美国拥有约 300 名专业人员。Novotech首席执行官 John Moller 博士表示:“这是一项战略举措,为希望在亚太地区和美国进行试验的美国客户以及希望在美国实施临床项目的亚太地区客户提供美国的专业技能和基础设施。”"通过系统的统一方法以及制定完善的标准操作规程,客户将获得无缝服务。” Moller表示。Novotech 最近被评为全球领先 CRO 中的前 10 名 CRO,并在过去 3 年中签署了 45 份领先的网站合作协议。凭借 2,000 多名经验丰富的专业人士,客户受益于强大的网站和关...

Read More

HG Semiconductor Enters into Cooperation Framework Agreement with China Titans Energy

HONG KONG, Jun 2, 2022 - (ACN Newswire via SEAPRWire.com) - HG Semiconductor Limited ("HG Semiconductor", together with its subsidiaries, "the Group"; stock code: 6908.HK) is pleased to announce that the Group entered into a cooperation framework agreement ("Cooperation Framework Agreement") with China Titans Energy Technology Group Co., Limited ("China Titans Energy"; Stock Code: 2188.HK) on 31 May 2022, to commence a three-year strategic cooperation.China Titans Energy focuses on the development of power electronics, aiming to use advanced technology of power electronics and automation control to address the needs of power transformation, supervision, controlling, optimisation, energy saving and new energy utilization. Pursuant to the Cooperation Framework Agreement, the Group and China Titans Energy intend to cooperate on fast charging pile technology promotion and product sales in Mainland China and Hong Kong, to promote complementarity between the strength of both parties in their respective business areas:i) China Titans Energy will provide support for the Group to build advanced fast charging pile products, run fast charging pile services in Hong Kong and jointly launch fast...

Read More

The 11th Edition of the Big CIO Show & Awards was Convened by CIOs to Broaden the Horizons of Leadership

New Delhi, India, Jun 2, 2022 - (ACN Newswire via SEAPRWire.com) - India played host to one of the most content-rich conferences that took place at Taj Lands End in Mumbai on 18th May 2022. Hosted by leading global business events and consulting firm Trescon, the show included a glittering awards ceremony with the 'INNOVATOR'S AWARDS' and 'LEADER'S AWARDS' honoring more than 100 CIOs and tech leaders in India. The event featured prominent global technology providers who showcased innovative enterprise technology solutions that help businesses become more efficient and resilient to market conditions.The show featured discussions on some of the most trending opportunities and challenges including: The future of digital leadership; Data-first, data-anywhere business model; Next gen data and AI platforms; Data in motion; Winning WhatsApp commerce strategy; Value proposition of cloud-centric virtual worlds; Automation and composable technology; and Roadmap to a secure and scalable hybrid workforce, to name a few.Dr. Neeta Verma, Director General, National Informatics Centre, MeitY, spoke at length on the topic 'Reimagining a Digital Nation with Innovation & Sustainability at its Cor...

Read More

Novotech Sponsors Pre-ASCO China Summit Expert Panels on Early Phase Oncology Trials and Regulatory Strategy for China and US

SYDNEY, Jun 2, 2022 - (ACN Newswire via SEAPRWire.com) - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, has sponsored expert panels at the Pre-ASCO China Summit 2022 bringing together leaders in oncology drug development in China and the US. The Pre-ASCO series was watched by more than 20,000 people globally.The Novotech sponsored Summit sessions are:- Go/No Go Decisions Based on Early Phase Oncology Trials (Watch here: https://tinyurl.com/novotech-webinars)- Development and Regulatory Strategy for China & US (Watch here: https://tinyurl.com/novotech-whitepapers)China offers a compelling solution for expedited clinical trials especially in oncology with its vast patient populations and world-class KOLs.-- According to Global Data whitepaper, EVOLUTION OF CLINICAL TRIALS IN THE ASIA PACIFIC REGION COMPARED TO THE US AND THE EU5 (https://tinyurl.com/novotech-whitepapers)- Over the past 5 years, growth of oncology trials (CAGR of 25%) in China outpaced other countries.- This growth was associated with a significant increase in cancer incidence, development of innovative products by domestic companies, focus on immuno-o...

Connected Transactions Involving Subscription by Vivo Suzhou Fund and Centerlab for TOT BIOPHARM Shares

HONG KONG, Jun 2, 2022 - (ACN Newswire via SEAPRWire.com) - On June 1, 2022, TOT BIOPHARM (Stock code: 1875. HK) announced that the company entered into a Share Subscription Agreement with VIVO Suzhou Fund and Centerlab. Pursuant to the agreement, Vivo Suzhou Fund and Centerlab agreed to subscribe for 116,250,000 and 33,750,000 shares of TOT BIOPHARM, respectively, at a subscription price of HK$3.15 per share (Premium issuance based on the past 5 trading days) , with a total of 150,000,000 shares, accounting for approximately 24.38% of the company's issued capital as of the date of this announcement. After the completion of the subscription agreement, assuming that all outstanding share options under the company's Pre-IPO Share Option Scheme will not be exercised before completion, the shareholding ratio of Vivo Suzhou Fund and Centerlab will reach approximately 28.68% and 28.66%.In recent years, TOT BIOPHARM has accelerated its strategic adjustment, strengthened its competitive advantage in the antibody conjugated drugs (ADC) field, and facilitated the construction of an industry-leading ADC one-stop commercialization platform. The company has made every effort to expand its one-s...

Read More

The Summit at Lan Space Concludes Successfully

DAVOS, SWITZERLAND, Jun 2, 2022 - (ACN Newswire via SEAPRWire.com) - A week of powerful conversations, immersive activities, and headline performances featured The Summit at Lan Space (www.thelan.space) as one of the most prominent events on the promenade, where some of the brightest minds around the globe were brought together during the annual Economic Meeting in Davos.- Headline speakers like Deepak Chopra, Sian Proctor, Tessy De Nassau, Nik Gowing, Leonor Diaz Alcantara, and Helena Gualinga took center stage to advocate for audiences to keep collaboration, empathy, and empowerment at the forefront of their leadership in seismic times. - Over five days, a platform was designed for innovative thinking with discussions converging on some of the most crucial conversations of our times: deglobalization and new geopolitical balances, disruptive decentralization in the age of Web3.0, solidarity in sustainability, and the future of leadership.With the rugged snow-capped setting of the Swiss Alps transformed by the picturesque view of the mountain meadows in May, last week the participation of more than 200 impact investors and 1000 delegates at The Lan Space successfully concluded five...

Read More

The 20th CIEP: Serving Scientific and Technological Innovation and Promoting Exchange

SHENZHEN, CHINA, Jun 1, 2022 - (ACN Newswire via SEAPRWire.com) - The 20th Conference on International Exchange of Professionals (CIEP 2022) opened online May 26, kicking-off at the Shenzhen Forum with the theme "Accelerate the Building of Talent Centers and Global Innovation Hubs".Following the concept of innovation as its primary resource, and establishing a strategy of innovation-led development, China is creating a favorable atmosphere of 'Pooling global talent and innovation, to best use', said Wang Zhigang, China's Minister of Science and Technology, in the opening keynote speech.China upholds globalization, and has established scientific and technological cooperation with more than 160 countries and regions worldwide, while participating in more than 200 international organizations and multilateral agreements, Wang said.Committed to further opening up its science and technology sector with a broader vision and more pragmatic measures, China will continue building international scientific programs and facilitating communication on innovative strategies.China is actively building an international science and technology platform, joining hands with global researchers, and promo...

Read More

Financial services veteran Dato’ Seri Dr Mohamed Azahari joins auction technology firm BidNow as new Corporate Advisor

KUALA LUMPUR, Jun 1, 2022 - (ACN Newswire via SEAPRWire.com) - BidNow, one of Malaysian's largest auction technology platform, has appointed Dato' Seri Dr Mohamed Azahari Kamil as its new Corporate Advisor with immediate effect. His appointment is expected to spur the company's growth and further develop its tremendous potential for robust auction sales.In his new role, Mohamed Azahari will be contributing his wealth of experience in the corporate world to facilitate BidNow's further expansion domestically and internationally, as well as lead the company towards an initial public offering (IPO) stage.Mohamed Azahari, who has previously held positions as chief executive officer of Asian Finance Bank Bhd and group managing director of QSR Brands (M) Holdings Bhd (which operates over 1,250 KFC and Pizza Hut restaurants), has had a distinguished career in several industries such as financial services, property, F&B, education and more. Some of the other private and public organisations that he held senior management posts in prior to this include KPJ Healthcare Bhd, Malaysian Industrial Development Finance Berhad, Permodalan Nasional Berhad Group and Amanah Raya Group.He is also cu...

Read More

SESAMi Holding acquires MyBiz in all-cash deal boosting regional footprint

SINGAPORE, Jun 1, 2022 - (ACN Newswire via SEAPRWire.com) - SESAMi Holding Pte Ltd (SESAMi) announced the successful acquisition of MyBiz Solutions Sdn Bhd.The all-cash deal is immediately profit-accretive and provides SESAMi with an additional revenue stream as well as an opportunity to strengthen SESAMi's portfolio of businesses. The company also believes that the acquisition has the potential to significantly value-add to existing and potential customers of both SESAMi and MyBiz.Mr Ong Teck Soon, SESAMi Holding's Chairman and CEO said, "We have been actively exploring various strategic acquisition opportunities to strengthen SESAMi's suite of products and services and enable the Company to provide a more robust business solution to our customers, thereby helping us grow revenue. The acquisition, when completed, is expected to enable us to capture new opportunities within the fast-growing online transactional commerce business in the region and we are confident of the industry's significant long-term growth prospects."Award-winning MyBiz has emerged as an Asian leader in spend management and strategic sourcing solutions with more than 20 years of experience and expertise in their...

Read More

宏光半导体与中国泰坦能源订立合作框架协议

HONG KONG, Jun 1, 2022 - (亚太商讯 via SEAPRWire.com) - 宏光半导体有限公司(「宏光半导体」,连同其附属公司统称「集团」;股份代号:6908.HK)欣然宣布集团于2022年5月31日与中国泰坦能源技术集团有限公司(「中国泰坦能源」;股份代号:2188.HK)订立合作框架协议(「合作框架协议」),开展为期三年的战略合作。中国泰坦能源专注在电子电力领域发展,旨在运用先进的电力电子和自动控制技术,解决电能的转换、监测、控制、优化、节能和新能源利用的需求。根据合作框架协议,集团与中国泰坦能源拟就中国及香港之快速充电桩技术推广及产品销售进行合作,促进双方在各自领域之优势互补﹕一、 中国泰坦能源将为集团打造先进的快速充电桩产品,在香港开展快速充电桩服务并共同推出快速充电系统解决方案提供支持。双方将善用集团与香港法定机构合作的独特优势,共同推进香港于智慧城市方面的发展,升级香港的电动车及充电设施,藉以实现符合国际标准的400千瓦直流充电及利用云数据及安全监测等智能管理。此新能源快速充电解决方案预计将成为领先的解决方案,同时创造新本地商业模式及投资机会,如建设汽车对电网(V2G)之技术、分布式储能及电网级直流变电站等;二、 双方将合作研发采用集团所提供的第三代半导体技术的新一代快速充电桩;及三、 宏光半导体将委聘中国泰坦能源制造并向集团在中国内地及香港之客户供应其品牌旗下之新一代快速充电桩。国家之「十四五」规划下的《新能源汽车产业发展规划(2021-2035)》部署了五项战略任务,包括i)提高技术创新能力、ii)构建新型产业生态、iii)推动产业融合发展、iv)完善基础设施体系,以及v)深化开放合作;同时明确指出要建立以企业为主体的技术创新体系、加强充换电等的基础设施,且电池管理系统及电池亦一致被认定为重点开发技术之一。与此同时,香港政府亦公布了香港电动车普及化路线图,目标于2050年前达致所有车辆零排放,让香港有序迈进零碳排放、清新空气、智慧城市的愿景。香港政府近年积极推动「再工业化」,发展以新技术及智能生产为基础的先进制造业,为宏光导体在发展第三代半导体氮化镓(「GaN」)的业务注入源源动力。集团管理层表示很荣幸能与中国泰坦能源成为合作伙伴,以推动香港下一代半导体行业的「再工业化」及香港于智慧城市方面的发展及建设。集团于2021年已获取六项关于充电站的快速充电蓄电池系统、充电转换系统及充电模块以及适用于电动汽车充电站的快速充电设备的专利,而是次合作标志着宏光半导体逐步迈向收成期之目标,为集团提供以自有品牌于中国内地及香港商业化其快速充电电池产品的机遇,加快实现产能落地之步伐。随着电动汽车于中国内地及香港日益普及并大行其道,于中港两地开发及商业化新一代充电桩的业务前景可期。集团将致力探索于香港建立快速充电电池解决方案业务据点之...

Read More

SingSing, Sing-to-Earn Project with AI Scoring Technology Soon to Become a Musical SocialFi Platform

Ho Chi Minh City, Vietnam, June 1, 2022 - (ACN Newswire via SEAPRWire.com) - SING SING PTE. LTD. (SingSing) officially announced the successful integration of Artificially Intelligent Scoring Technology into the SingSing App, allowing automatic scoring of the singer's performance. SingSing's AI Scoring Technology is based on three criteria: First, evaluation is based on voice-related factors, including the right music, the voice quality and whether it reflects the chosen favorite singer well. Second, when performing with the camera on, AI Scoring Technology evaluates the singer's appearance based on the standard facial proportions. Finally, during the singing process, singers' facial expressions are also evaluated in comparison to the song. This is a breakthrough in community connection because this one-of-a-kind AI Scoring Technology is not only capable of interacting with, but also helping to connect millions of people who love to sing together at the same time.Sing-to-Earn towards a SocialFi platform in the music industry.In addition to its technological prowess, SingSing has connected with more than 30 famous Asian singers, with more than 40 million fans across Asia. Furthermor...

维梧苏州基金及晟德大药厂认购东曜药业股份

HONG KONG, Jun 1, 2022 - (亚太商讯 via SEAPRWire.com) - 东曜药业(股票代码:1875.HK)宣布公司与维梧苏州基金及晟德大药厂订立股份认购协议。根据协议,维梧苏州基金与晟德大药厂将分别认购东曜药业配售股份116,250,000股及33,750,000股,认购价每股 3.15港元(依据过往5个交易日溢价发行),合共150,000,000股,占本公告日期公司已发行股本约24.38%。本次认购协议完成后,假设公司首次公开发售前购股权计划下未获行使购股权于完成前均不会获行使,维梧苏州基金与晟德大药厂持股占比将分别达约28.68%及28.66%。近年以来东曜药业加速战略调整,强化公司在抗体偶联药物(ADC)领域的竞争优势, 并加快建设行业领先的ADC一站式产业化平台;全力拓展一站式创新药CDMO业务,目前已经取得突破性成果,业务规模大幅增长,成为公司发展新引擎。本次股份认购募集资金总额达4.7亿港元(约合人民币4亿元),该款项将改善公司的流动资金,扩大公司资本基础,优化公司资本架构,为公司的长期发展提供支持。资金拟重点用于:进一步拓展CDMO业务,加强与国内外制药公司的项目合作;推动全球研发中心持续建设,提升ADC商业化生产能力,从而提升成本效益;完成TAA013的III期临床试验,以及TAE020、TAC020等在研药物的临床前及临床试验;开展朴欣汀®、替至安®及美适亚®的商业化生产和市场营销等。东曜药业董事长、维梧资本管理合伙人、全球联席CEO及亚洲区CEO付山先生表示:“本次交易是东曜药业发展道路上的又一重大里程碑,其清晰的战略规划和良好的业绩表现获得了股东的高度认可。近年来,东曜药业管理团队不断聚焦核心竞争优势、优化资源配置,坚定差异化发展之路,打造了国内领先、具有国际竞争力的ADC全产业链平台,积极拓展CDMO业务,搭建了极具竞争优势和产业价值的商业化生产平台,展现出强劲、持续的发展潜力,公司股东及董事会对公司未来发展充满信心!”东曜药业首席执行官刘军博士表示:“非常荣幸能够在公司提升商业化发展及以ADC为核心进行战略调整的关键时期获得两大股东维梧资本和晟德大药厂的鼎力支持和认可!东曜药业向ADC CDMO的战略转型升级已取得显著成果,通过本次增资,将进一步充实公司的资本实力,为公司持续发展提供资金支持。未来,东曜药业将继续优化资本结构,建立多元及可持续发展模式;不断提升工艺开发综合实力,加速ADC商业化产能升级,打造CDMO业务成长新引擎,从而强化公司自身造血能力,以期为广大股东和投资人创造丰厚回报。”关于维梧苏州基金及Vivo Capital LLC管理的其他基金维梧苏州基金为一间于中国成立由一间于中国证券投资基金业协会注册的私募基金管理人维梧股权投资管理(上海)有限公司(由Vivo Capital LLC...